PATENT CLAIM ANALYSIS

Application Number: 15772938
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["435", "007100"]

Abstract:
The level of exosomal polypeptides in a sample from a patient who has received a transplant is assayed and used as an indicator for transplant rejection. Based on the measured level of the exosomal polypeptides, therapeutic intervention, such as an immunosuppressant therapy, may be started, adjusted, continued or discontinued.

Claim (Index 27):
The method of any of  claims 1 ,  2 ,  9  or  10 , wherein the transplant rejection is chronic transplant rejection.

Metadata:
- Claim Count in Document: 58.0
- Percentile: 93.0
- Lexical Diversity: 1.36585
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14591542', '13009393', '13009285', '13635667', '14170132']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5793103959471065
- 35 USC 102 Novelty (BERT): 0.5197086595007381
- Combined Prediction Score: 0.5733502223024697
- Mean Citation Score: 247.684926
- Max Citation Score: 253.45285
- Similarity Product: 146.0709870025456

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test